Source: The American Prospect
by David Dayen
“All week, we are focused on the new executive actions President Trump is putting forward rapid-fire. But I’m also interested in the actions Trump is obligated to complete, as part of the natural course of the government. One of the most important will be what he does with the ongoing effort to reduce prescription drug prices for tens of millions of Americans. As president, Biden signed the Inflation Reduction Act, and one of its bigger inflation-reducing elements was enabling Medicare to negotiate prices with drug companies. This law has survived every effort to overturn it in court, and while it’s only gotten started, it expands as time goes on. Ten drugs were selected for the first round, producing lower prices by up to 79 percent and an estimated government savings of $6 billion in year one when the prices become effective, as well as $1.5 billion in out-of-pocket savings for seniors.” (01/22/25)
https://prospect.org/health/2025-01-22-trumps-big-choice-drug-prices/